Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Intensive Treatment Regimen for Severe NTM-PD
NCT05494957Phase 4Unknown
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Aug 2022
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bedaquiline in nontuberculous mycobacterial lung disease, sponsored by Shanghai Pulmonary Hospital. Status: unknown.
02
Drugs
bedaquiline
03
Conditions
nontuberculous mycobacterial lung disease
Beyond the preview
Go deeper on NCT05494957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05494957.